MRLOX
Price
$18.85
Change
-$0.11 (-0.58%)
Updated
Oct 7 closing price
Net Assets
17.16B
RLBAX
Price
$38.56
Change
-$0.09 (-0.23%)
Updated
Oct 7 closing price
Net Assets
266.1B
Interact to see
Advertisement

MRLOX vs RLBAX

Header iconMRLOX vs RLBAX Comparison
Open Charts MRLOX vs RLBAXBanner chart's image
BlackRock Global Allocation R
Price$18.85
Change-$0.11 (-0.58%)
VolumeN/A
Net Assets17.16B
American Funds American Balanced R1
Price$38.56
Change-$0.09 (-0.23%)
VolumeN/A
Net Assets266.1B
MRLOX vs RLBAX Comparison Chart in %
View a ticker or compare two or three
VS
MRLOX vs. RLBAX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRLOX is a Buy and RLBAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 266B vs. MRLOX (17.2B). MRLOX pays higher dividends than RLBAX: MRLOX (2.37) vs RLBAX (1.10). MRLOX was incepted earlier than RLBAX: MRLOX (23 years) vs RLBAX (23 years). MRLOX (1.49) is less costly to investors than RLBAX (1.31). MRLOX is a more actively managed with annual turnover of: 138.00 vs. RLBAX (44.00). MRLOX has a lower initial minimum investment than RLBAX: MRLOX (100) vs RLBAX (250). RLBAX annual gain was more profitable for investors over the last year : 9.12 vs. MRLOX (7.84). RLBAX return over 5 years is better than : 38.04 vs. MRLOX (2.03).
MRLOXRLBAXMRLOX / RLBAX
Total Expense Ratio1.461.31111%
Annual Report Gross Expense Ratio1.491.31114%
Fund Existence23 years23 years-
Gain YTD12.13413.77088%
Front LoadN/AN/A-
Min. Initial Investment10025040%
Min. Initial Investment IRAN/AN/A-
Net Assets17.2B266B6%
Annual Yield % from dividends2.371.10215%
Returns for 1 year7.849.1286%
Returns for 3 years34.0447.9871%
Returns for 5 years2.0338.045%
Returns for 10 years6.9168.7210%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WLY38.330.03
+0.09%
John Wiley & Sons
ROIV16.12-0.14
-0.86%
Roivant Sciences Ltd
PRLD1.44-0.02
-1.37%
Prelude Therapeutics
IVP0.98-0.03
-3.18%
Inspire Veterinary Partners Inc
GRRR19.99-0.68
-3.29%
Gorilla Technology Group